The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,274,739 in first-year total cost, median $819,047.
Most frequent study sections
- Special Emphasis Panel[ZAI1 BLF-A (J2)]2
- Special Emphasis Panel[ZAI1 DR-A (J2)]1
Most frequent institutions
- OREGON HEALTH & SCIENCE UNIVERSITY1
- TEXAS BIOMEDICAL RESEARCH INSTITUTE1
- UNIVERSITY OF ROCHESTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Trans-complementing papillioma virus for AIDS vaccine1R01AI117862-01 | GAUDUIN, MARIE-CLAIRE ELISABETH | TEXAS BIOMEDICAL RESEARCH INSTITUTE, TX | $904,454 | ZAI1 |
| 2015 | A universal MHC-E-restricted T cell vaccine for HIV1R01AI117802-01 | SACHA, JONAH B. | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $819,047 | ZAI1 |
| 2015 | Targeting IgM Memory to Establish Protective B Cell Responses to HIV1R01AI117787-01 | KOBIE, JAMES J | UNIVERSITY OF ROCHESTER, NY | $551,238 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.